Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Feb;75(2):159–164. doi: 10.1136/hrt.75.2.159

Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure.

R J de Vries 1, P H Dunselman 1, U G Chin Kon Sung 1, D J van Veldhuisen 1, H M Corbeij 1, W H van Gilst 1, K I Lie 1
PMCID: PMC484252  PMID: 8673754

Abstract

OBJECTIVE: To evaluate the efficacy and safety of the second generation dihydropyridine calcium channel blocker lacidipine in patients with heart failure. DESIGN: Placebo controlled, parallel group, double blind study over 8 weeks. SETTING: General community hospital in Breda, The Netherlands. PATIENTS: A random sample was studied of 25 outpatients with symptoms of mild to moderate heart failure, despite treatment with diuretics, digoxin, and angiotensin converting enzyme inhibitors. Their mean age was 65 years, with mean left ventricular ejection fraction of 0.24 and a peak oxygen consumption of 14.4 ml/min/kg. Two patients dropped out on lacidipine, one patient on placebo. INTERVENTION: Treatment with lacidipine 4 mg once daily or placebo for eight weeks. MAIN OUTCOME MEASURE: Cardiopulmonary exercise testing, invasive haemodynamics, and plasma neurohormones. RESULTS: Treatment with lacidipine 4 mg once daily, as compared to placebo treatment, significantly improved peak oxygen consumption (P < 0.02), cardiac index (P < 0.01), and stroke volume (P < 0.03) paralleled by a decrease in systemic vascular resistance (P < 0.03) and arteriovenous oxygen content difference (P < 0.01). Plasma noradrenaline, plasma renin activity, and aldosterone values did not differ between lacidipine and placebo. CONCLUSIONS: This second generation dihydropyridine may be of value as an adjunct to standard treatment in congestive heart failure patients.

Full text

PDF
159

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonnier H. J., Visser R. F., Klomps H. C., Hoffmann H. J. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction. Am J Cardiol. 1988 Jul 1;62(1):25–30. doi: 10.1016/0002-9149(88)91359-8. [DOI] [PubMed] [Google Scholar]
  2. Burow R. D., Strauss H. W., Singleton R., Pond M., Rehn T., Bailey I. K., Griffith L. C., Nickoloff E., Pitt B. Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography. Circulation. 1977 Dec;56(6):1024–1028. doi: 10.1161/01.cir.56.6.1024. [DOI] [PubMed] [Google Scholar]
  3. Cody R. J., Franklin K. W., Kluger J., Laragh J. H. Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril. Am J Med. 1982 May;72(5):791–797. doi: 10.1016/0002-9343(82)90547-2. [DOI] [PubMed] [Google Scholar]
  4. Cohn J. N. The prevention of heart failure--a new agenda. N Engl J Med. 1992 Sep 3;327(10):725–727. doi: 10.1056/NEJM199209033271010. [DOI] [PubMed] [Google Scholar]
  5. Dunselman P. H., Kuntze C. E., van Bruggen A., Beekhuis H., Piers B., Scaf A. H., Wesseling H., Lie K. I. Value of New York Heart Association classification, radionuclide ventriculography, and cardiopulmonary exercise tests for selection of patients for congestive heart failure studies. Am Heart J. 1988 Dec;116(6 Pt 1):1475–1482. doi: 10.1016/0002-8703(88)90731-4. [DOI] [PubMed] [Google Scholar]
  6. Dunselman P. H., Kuntze C. E., van Bruggen A., Hamer J. P., Scaf A. H., Wessling H., Lie K. I. Efficacy of felodipine in congestive heart failure. Eur Heart J. 1989 Apr;10(4):354–364. doi: 10.1093/oxfordjournals.eurheartj.a059493. [DOI] [PubMed] [Google Scholar]
  7. Elkayam U., Amin J., Mehra A., Vasquez J., Weber L., Rahimtoola S. H. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation. 1990 Dec;82(6):1954–1961. doi: 10.1161/01.cir.82.6.1954. [DOI] [PubMed] [Google Scholar]
  8. Elkayam U., Weber L., McKay C., Rahimtoola S. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. Am J Cardiol. 1985 Sep 15;56(8):560–566. doi: 10.1016/0002-9149(85)91185-3. [DOI] [PubMed] [Google Scholar]
  9. Ferguson D. W., Berg W. J., Sanders J. S., Roach P. J., Kempf J. S., Kienzle M. G. Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation. 1989 Jul;80(1):65–77. doi: 10.1161/01.cir.80.1.65. [DOI] [PubMed] [Google Scholar]
  10. Firth B. G., Dehmer G. J., Markham R. V., Jr, Willerson J. T., Hillis L. D. Assessment of vasodilator therapy in patients with severe congestive heart failure: limitations of measurements of left ventricular ejection fraction and volumes. Am J Cardiol. 1982 Nov;50(5):954–959. doi: 10.1016/0002-9149(82)90401-5. [DOI] [PubMed] [Google Scholar]
  11. Haq A., Rakowski H., Baigrie R., McLaughlin P., Burns R., Tihal H., Hilton D., Feiglin D. Vasodilator therapy in refractory congestive heart failure: a comparative analysis of hemodynamic and noninvasive studies. Am J Cardiol. 1982 Feb 1;49(2):439–444. doi: 10.1016/0002-9149(82)90522-7. [DOI] [PubMed] [Google Scholar]
  12. Ho K. K., Anderson K. M., Kannel W. B., Grossman W., Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993 Jul;88(1):107–115. doi: 10.1161/01.cir.88.1.107. [DOI] [PubMed] [Google Scholar]
  13. Kassis E., Amtorp O. Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure. Circulation. 1987 Jun;75(6):1204–1213. doi: 10.1161/01.cir.75.6.1204. [DOI] [PubMed] [Google Scholar]
  14. Kassis E., Amtorp O. Long-term clinical, hemodynamic, angiographic, and neurohumoral responses to vasodilation with felodipine in patients with chronic congestive heart failure. J Cardiovasc Pharmacol. 1990 Mar;15(3):347–352. doi: 10.1097/00005344-199003000-00001. [DOI] [PubMed] [Google Scholar]
  15. Koolen J. J., Van Wezel H. B., Piek J., van Liebergen R., Swaan A., Visser C. A. Effects of intracoronary felodipine versus nifedipine on left ventricular contractility and coronary sinus blood flow in stable angina pectoris. Am J Cardiol. 1994 Oct 1;74(7):730–732. doi: 10.1016/0002-9149(94)90320-4. [DOI] [PubMed] [Google Scholar]
  16. NAIMARK A., WASSERMAN K., MCILROY M. B. CONTINUOUS MEASUREMENT OF VENTILATORY EXCHANGE RATIO DURING EXERCISE. J Appl Physiol. 1964 Jul;19:644–652. doi: 10.1152/jappl.1964.19.4.644. [DOI] [PubMed] [Google Scholar]
  17. Packer M. Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy. Circulation. 1990 Dec;82(6):2254–2257. doi: 10.1161/01.cir.82.6.2254. [DOI] [PubMed] [Google Scholar]
  18. Schofer J., Hobuss M., Aschenberg W., Tews A. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study. Eur Heart J. 1990 Aug;11(8):712–721. doi: 10.1093/oxfordjournals.eurheartj.a059786. [DOI] [PubMed] [Google Scholar]
  19. Tan L. B., Murray R. G., Littler W. A. Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects. Br Heart J. 1987 Aug;58(2):122–128. doi: 10.1136/hrt.58.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. van Veldhuisen D. J., Man in 't Veld A. J., Dunselman P. H., Lok D. J., Dohmen H. J., Poortermans J. C., Withagen A. J., Pasteuning W. H., Brouwer J., Lie K. I. Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT). J Am Coll Cardiol. 1993 Nov 15;22(6):1564–1573. doi: 10.1016/0735-1097(93)90579-p. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES